Form 4: Generation Bio Co. Executive Phillip Samayoa Reports Stock Transactions

Phillip Samayoa, Chief Scientific Officer of Generation Bio Co., reports the acquisition and disposal of common stock and restricted stock units.

Summary

• On April 15, 2025, Phillip Samayoa, the Chief Scientific Officer of Generation Bio Co., engaged in transactions involving the company's common stock and restricted stock units.
• Samayoa acquired 1,147 shares of common stock through the vesting of restricted stock units.
• Samayoa disposed of 337 shares of common stock at a price of $0.3678.
• Following these transactions, Samayoa directly owns 128,519 shares of common stock.
• Samayoa also directly owns 8,023 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It is important for investors to monitor these filings as they can provide insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company executives as it can provide insights into their confidence in the company's future prospects.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transactions, Restricted Stock Units, Generation Bio Co., GBIO, Phillip Samayoa, Executive Compensation